These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 19910037

  • 1. Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall.
    Spahn J, Sheth K, Yeh WS, Stempel DA, Stanford RH.
    J Allergy Clin Immunol; 2009 Dec; 124(6):1197-203. PubMed ID: 19910037
    [Abstract] [Full Text] [Related]

  • 2. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
    Hagiwara M, Delea TE, Stanford RH.
    Allergy Asthma Proc; 2014 Dec; 35(1):54-62. PubMed ID: 24433597
    [Abstract] [Full Text] [Related]

  • 3. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA, Riedel AA, Carranza Rosenzweig JR.
    Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
    [Abstract] [Full Text] [Related]

  • 4. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.
    Stanford RH, Blanchette CM, Roberts MH, Petersen H, Fuhlbrigge AL.
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):343-51. PubMed ID: 23083688
    [Abstract] [Full Text] [Related]

  • 5. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
    Tunceli O, Williams SA, Kern DM, Elhefni H, Pethick N, Wessman C, Zhou S, Trudo F.
    J Allergy Clin Immunol Pract; 2014 Dec; 2(6):719-26. PubMed ID: 25439363
    [Abstract] [Full Text] [Related]

  • 6. An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes .
    Stanford RH, Fuhlbrigge A, Riedel A, Rey GG, Stempel DA.
    Curr Med Res Opin; 2008 Nov; 24(11):3141-8. PubMed ID: 18838055
    [Abstract] [Full Text] [Related]

  • 7. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [Abstract] [Full Text] [Related]

  • 8. Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare.
    Nguyen WT, Stewart C, Fisher K, Tolley E, Lew DB, Self TH.
    Allergy Asthma Proc; 2005 Feb; 26(2):129-34. PubMed ID: 15971472
    [Abstract] [Full Text] [Related]

  • 9. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE, Hagiwara M, Stanford RH, Stempel DA.
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [Abstract] [Full Text] [Related]

  • 10. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder.
    Hagiwara M, Delea TE, Stanford RH.
    J Asthma; 2013 Apr; 50(3):287-95. PubMed ID: 23305687
    [Abstract] [Full Text] [Related]

  • 11. Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens.
    O'Connor RD, Rosenzweig JR, Stanford RH, Gilmore AS, Ryskina KL, Legorreta AP, Stempel DA.
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):535-40. PubMed ID: 16400892
    [Abstract] [Full Text] [Related]

  • 12. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
    Hagiwara M, Delea TE, Stanford RH, Stempel DA.
    Allergy Asthma Proc; 2010 Dec; 31(3):203-10. PubMed ID: 20534183
    [Abstract] [Full Text] [Related]

  • 13. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.
    Katial RK, Oppenheimer JJ, Ostrom NK, Mosnaim GS, Yancey SW, Waitkus-Edwards KR, Prillaman BA, Ortega HG.
    Allergy Asthma Proc; 2010 Dec; 31(1):68-75. PubMed ID: 20167147
    [Abstract] [Full Text] [Related]

  • 14. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol.
    Blais L, Beauchesne MF, Forget A.
    Respir Med; 2009 Feb; 103(2):237-43. PubMed ID: 18930647
    [Abstract] [Full Text] [Related]

  • 15. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.
    Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM.
    Curr Med Res Opin; 2009 Jan; 25(1):1-13. PubMed ID: 19210134
    [Abstract] [Full Text] [Related]

  • 16. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 17. The effect of fixed combination of fluticasone and salmeterol on asthma drug utilization, asthma drug cost, and episodes of asthma exacerbations.
    Brixner DI, Lenhart G, Young DC, Samuelson WM.
    Curr Med Res Opin; 2007 Nov; 23(11):2887-95. PubMed ID: 17922979
    [Abstract] [Full Text] [Related]

  • 18. Adherence to asthma controller medication regimens.
    Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [Abstract] [Full Text] [Related]

  • 19. Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.
    Delea TE, Stanford RH, Hagiwara M, Stempel DA.
    Curr Med Res Opin; 2008 Dec; 24(12):3435-42. PubMed ID: 19032125
    [Abstract] [Full Text] [Related]

  • 20. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.